Cryo-Cell International, Inc. (CCEL)
USD 7.65
(-4.26%)
USD 7.65
(-4.26%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 10.89 Million USD | -6.18% |
| 2022 | 11.61 Million USD | 311.68% |
| 2021 | 2.82 Million USD | -54.79% |
| 2020 | 6.24 Million USD | -30.32% |
| 2019 | 8.95 Million USD | -30.81% |
| 2018 | 12.94 Million USD | 77.43% |
| 2017 | 7.29 Million USD | -25.71% |
| 2016 | 9.81 Million USD | 734.75% |
| 2015 | 1.17 Million USD | -48.85% |
| 2014 | 2.3 Million USD | 0.0% |
| 2013 | 2.3 Million USD | 0.0% |
| 2012 | 2.3 Million USD | -38.67% |
| 2011 | 3.75 Million USD | -99.77% |
| 2010 | 1.62 Billion USD | -23.91% |
| 2009 | 2.13 Billion USD | 73.79% |
| 2008 | 1.22 Billion USD | -7.9% |
| 2007 | 1.33 Billion USD | -21.98% |
| 2006 | 1.7 Billion USD | 45.6% |
| 2005 | 1.17 Billion USD | -12.35% |
| 2004 | 1.33 Billion USD | 921985.52% |
| 2003 | 145 Thousand USD | 10212.94% |
| 2002 | 1406.00 USD | -99.7% |
| 2001 | 476.08 Thousand USD | 2597.08% |
| 2000 | 17.65 Thousand USD | -91.17% |
| 1999 | 200 Thousand USD | -81.82% |
| 1998 | 1.1 Million USD | 120.0% |
| 1997 | 500 Thousand USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 11.55 Million USD | 6.06% |
| 2024 Q3 | 10.72 Million USD | -14.48% |
| 2024 Q2 | 13.71 Million USD | 18.71% |
| 2023 FY | 10.89 Million USD | -6.18% |
| 2023 Q2 | 11.62 Million USD | 5.62% |
| 2023 Q4 | 10.89 Million USD | -12.73% |
| 2023 Q1 | 11 Million USD | -5.2% |
| 2023 Q3 | 12.48 Million USD | 7.36% |
| 2022 Q4 | 11.61 Million USD | 22.85% |
| 2022 Q3 | 9.45 Million USD | 738.95% |
| 2022 Q1 | 1.97 Million USD | -29.95% |
| 2022 Q2 | 1.12 Million USD | -42.98% |
| 2022 FY | 11.61 Million USD | 311.68% |
| 2021 Q3 | 3.66 Million USD | -18.59% |
| 2021 FY | 2.82 Million USD | -54.79% |
| 2021 Q1 | 5.19 Million USD | -16.68% |
| 2021 Q2 | 4.49 Million USD | -13.52% |
| 2021 Q4 | 2.82 Million USD | -22.94% |
| 2020 Q1 | 8.7 Million USD | -2.84% |
| 2020 Q2 | 7.88 Million USD | -9.39% |
| 2020 Q3 | 7.06 Million USD | -10.41% |
| 2020 Q4 | 6.24 Million USD | -11.66% |
| 2020 FY | 6.24 Million USD | -30.32% |
| 2019 Q1 | 12.19 Million USD | -5.76% |
| 2019 Q2 | 11.45 Million USD | -6.12% |
| 2019 FY | 8.95 Million USD | -30.81% |
| 2019 Q3 | 9.7 Million USD | -15.26% |
| 2019 Q4 | 8.95 Million USD | -7.71% |
| 2018 Q4 | 12.94 Million USD | -11.88% |
| 2018 FY | 12.94 Million USD | 77.43% |
| 2018 Q3 | 14.68 Million USD | 131.44% |
| 2018 Q2 | 6.34 Million USD | -6.97% |
| 2018 Q1 | 6.82 Million USD | -6.49% |
| 2017 Q4 | 7.29 Million USD | -6.07% |
| 2017 FY | 7.29 Million USD | -25.71% |
| 2017 Q1 | 9.35 Million USD | -4.74% |
| 2017 Q2 | 8.88 Million USD | -5.0% |
| 2017 Q3 | 7.76 Million USD | -12.6% |
| 2016 Q4 | 9.81 Million USD | -7.8% |
| 2016 Q2 | 650.1 Thousand USD | -40.95% |
| 2016 FY | 9.81 Million USD | 734.75% |
| 2016 Q3 | 10.65 Million USD | 1538.22% |
| 2016 Q1 | 1.1 Million USD | -6.41% |
| 2015 Q4 | 1.17 Million USD | -5.95% |
| 2015 Q2 | 2.3 Million USD | 0.0% |
| 2015 Q3 | 1.25 Million USD | -45.62% |
| 2015 FY | 1.17 Million USD | -48.85% |
| 2015 Q1 | 2.3 Million USD | 0.0% |
| 2014 Q3 | 2.3 Million USD | 0.0% |
| 2014 Q4 | 2.3 Million USD | 0.0% |
| 2014 Q2 | 2.3 Million USD | 0.0% |
| 2014 FY | 2.3 Million USD | 0.0% |
| 2014 Q1 | 2.3 Million USD | 0.0% |
| 2013 Q1 | 2.3 Million USD | 0.0% |
| 2013 Q4 | 2.3 Million USD | 0.0% |
| 2013 FY | 2.3 Million USD | 0.0% |
| 2013 Q3 | 2.3 Million USD | 0.0% |
| 2013 Q2 | 2.3 Million USD | 0.0% |
| 2012 Q2 | 2.65 Million USD | -7.02% |
| 2012 Q3 | 2.49 Million USD | -5.89% |
| 2012 Q1 | 2.85 Million USD | -24.0% |
| 2012 FY | 2.3 Million USD | -38.67% |
| 2012 Q4 | 2.3 Million USD | -7.78% |
| 2011 Q4 | 3.75 Million USD | 0.0% |
| 2011 Q2 | 1.8 Billion USD | 2.56% |
| 2011 Q1 | 1.75 Billion USD | 8.4% |
| 2011 FY | 3.75 Million USD | -99.77% |
| 2011 Q3 | 3.75 Million USD | -99.79% |
| 2010 Q2 | 1.83 Billion USD | 4.61% |
| 2010 FY | 1.62 Billion USD | -23.91% |
| 2010 Q1 | 1.75 Billion USD | -17.73% |
| 2010 Q4 | 1.62 Billion USD | -5.57% |
| 2010 Q3 | 1.71 Billion USD | -6.37% |
| 2009 Q2 | 1.45 Billion USD | 3.64% |
| 2009 Q3 | 1.64 Billion USD | 12.59% |
| 2009 Q4 | 2.13 Billion USD | 29.91% |
| 2009 FY | 2.13 Billion USD | 73.79% |
| 2009 Q1 | 1.4 Billion USD | 14.65% |
| 2008 Q4 | 1.22 Billion USD | -3.7% |
| 2008 Q3 | 1.27 Billion USD | 4.39% |
| 2008 FY | 1.22 Billion USD | -7.9% |
| 2008 Q1 | 1.38 Billion USD | 3.92% |
| 2008 Q2 | 1.21 Billion USD | -11.84% |
| 2007 Q4 | 1.33 Billion USD | 29.01% |
| 2007 FY | 1.33 Billion USD | -21.98% |
| 2007 Q3 | 1.03 Billion USD | 1.65% |
| 2007 Q2 | 1.01 Billion USD | -35.15% |
| 2007 Q1 | 1.56 Billion USD | -8.26% |
| 2006 FY | 1.7 Billion USD | 45.6% |
| 2006 Q1 | 1.12 Billion USD | -4.36% |
| 2006 Q3 | 1.75 Billion USD | 41.28% |
| 2006 Q4 | 1.7 Billion USD | -2.88% |
| 2006 Q2 | 1.24 Billion USD | 10.94% |
| 2005 Q1 | 853.79 Million USD | -36.14% |
| 2005 FY | 1.17 Billion USD | -12.35% |
| 2005 Q4 | 1.17 Billion USD | 64.58% |
| 2005 Q3 | 712.03 Million USD | -31.02% |
| 2005 Q2 | 1.03 Billion USD | 20.9% |
| 2004 Q4 | 1.33 Billion USD | 82.16% |
| 2004 Q2 | 2.06 Billion USD | 1056504.1% |
| 2004 Q1 | 195 Thousand USD | 34.48% |
| 2004 FY | 1.33 Billion USD | 921985.52% |
| 2004 Q3 | 733.98 Million USD | -64.38% |
| 2003 FY | 145 Thousand USD | 10212.94% |
| 2003 Q1 | 905.53 Million USD | 64404665.29% |
| 2003 Q3 | 100 Thousand USD | 0.0% |
| 2003 Q2 | - USD | -100.0% |
| 2003 Q4 | 145 Thousand USD | 45.0% |
| 2002 FY | 1406.00 USD | -99.7% |
| 2002 Q4 | 1406.00 USD | -40.57% |
| 2002 Q2 | 4408.00 USD | -99.15% |
| 2002 Q3 | 2366.00 USD | -46.32% |
| 2002 Q1 | 517.99 Thousand USD | 8.8% |
| 2001 FY | 476.08 Thousand USD | 2597.08% |
| 2001 Q1 | 15.6 Thousand USD | -11.59% |
| 2001 Q2 | 13.49 Thousand USD | -13.51% |
| 2001 Q4 | 476.08 Thousand USD | 4103.13% |
| 2001 Q3 | 11.32 Thousand USD | -16.08% |
| 2000 Q2 | 7265.00 USD | -69.16% |
| 2000 FY | 17.65 Thousand USD | -91.17% |
| 2000 Q1 | 23.55 Thousand USD | -88.22% |
| 2000 Q3 | 19.55 Thousand USD | 169.19% |
| 2000 Q4 | 17.65 Thousand USD | -9.74% |
| 1999 Q1 | - USD | -100.0% |
| 1999 FY | 200 Thousand USD | -81.82% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | 200 Thousand USD | 0.0% |
| 1998 Q3 | 600 Thousand USD | 0.0% |
| 1998 Q1 | 500 Thousand USD | 0.0% |
| 1998 Q2 | 600 Thousand USD | 20.0% |
| 1998 FY | 1.1 Million USD | 120.0% |
| 1998 Q4 | 1.1 Million USD | 83.33% |
| 1997 FY | 500 Thousand USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q4 | 500 Thousand USD | -16.67% |
| 1997 Q3 | 600 Thousand USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 99.279% |
| Addus HomeCare Corporation | 175.18 Million USD | 93.78% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | 89.068% |
| Amedisys, Inc. | 487.21 Million USD | 97.764% |
| American Oncology Network, Inc. | 128.32 Million USD | 91.509% |
| Astrana Health, Inc. | 321.01 Million USD | 96.606% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 99.273% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | 90.515% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -106.874% |
| COMPASS Pathways plc | 33.04 Million USD | 67.032% |
| DocGo Inc. | 46.49 Million USD | 76.566% |
| The Ensign Group, Inc. | 1.87 Billion USD | 99.418% |
| Healthcare Services Group, Inc. | 43.63 Million USD | 75.029% |
| InnovAge Holding Corp. | 113.03 Million USD | 90.36% |
| Assure Holdings Corp. | 14.8 Million USD | 26.403% |
| The Joint Corp. | 16.73 Million USD | 34.89% |
| LifeStance Health Group, Inc. | 511.04 Million USD | 97.868% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -1558.116% |
| ModivCare Inc. | 1.14 Billion USD | 99.044% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -3176.479% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -143.669% |
| Option Care Health, Inc. | 1.16 Billion USD | 99.066% |
| P3 Health Partners Inc. | 124.64 Million USD | 91.258% |
| P3 Health Partners Inc. | 124.64 Million USD | 91.258% |
| The Pennant Group, Inc. | 329.63 Million USD | 96.694% |
| Surgery Partners, Inc. | 3.06 Billion USD | 99.644% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -4291.736% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | 90.906% |
| The Oncology Institute, Inc. | 119.81 Million USD | 90.906% |